Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRIDEX CORP Director's Dealing 2013

Feb 7, 2013

34978_dirs_2013-02-07_b1a4fe02-57fe-4577-9f7c-1dcef88c99b8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2013-02-05

Reporting Person: Mackaness James H (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-02-05 Common Stock M 3000 $2.49 Acquired 5000 Direct
2013-02-05 Common Stock S 3000 $4.7073 Disposed 2000 Direct
2013-02-06 Common Stock M 3000 $2.49 Acquired 5000 Direct
2013-02-06 Common Stock S 3000 $4.7073 Disposed 2000 Direct
2013-02-07 Common Stock M 3000 $2.49 Acquired 5000 Direct
2013-02-07 Common Stock S 3000 $4.6584 Disposed 2000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-02-05 Stock Option Right to Buy $2.49 M 3000 Disposed 2015-01-02 Common Stock (3000) Direct
2013-02-06 Stock Option Right to Buy $2.49 M 3000 Disposed 2015-01-02 Common Stock (3000) Direct
2013-02-07 Stock Option Right to Buy $2.49 M 3000 Disposed 2015-01-02 Common Stock (3000) Direct

Footnotes

F1: The sale reported in this Form 4 was pursuant to the Reporting Person's Rule 10b5-1 Selling Plan that was effective March 12, 2012.

F2: This option was granted pursuant to IRIDEX Corporation's incentive 1998 Stock Plan and is exempt pursuant to Rule 16b-3.

F3: The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter.